Search

Your search keyword '"Menon, S."' showing total 8 results
Start Over Author "Menon, S." Journal indian journal of medical microbiology
8 results on '"Menon, S."'

3. Cutaneous histoplasmosis in AIDS

Author

Chande, C., Menon, S., Gohil, A., Lilani, S., Bade, J., Mohammad, S., and Joshi, A.

Subjects
Mycoses -- Care and treatment, Mycoses -- Health aspects, AIDS (Disease) -- Care and treatment, AIDS (Disease) -- Health aspects, Health
Abstract

A patient with human immunodeficiency virus (HIV) infection presented with multiple cutaneous lesions on upper extremities, trunk, face and with ulcers involving oral mucosa. Histoplasma capsulatum was isolated in culture [...]

Published
2010

5. Significance of HBV DNA by PCR over serological markers of HBV in acute and chronic patients

Author

Rodrigues C, Deshmukh M, Jacob T, Nukala R, Menon S, and Mehta A

Subjects
DNA amplification, lcsh:QR1-502, virus diseases, Hepatitis B virus (HBV), digestive system diseases, and serological markers, lcsh:Microbiology
Abstract

A study was undertaken to determine Hepatitis B virus DNA (HBV DNA) by PCR in acute and chronic hepatitis B infection and to correlate it with serological markers. Three hundred and forty-five serum samples of patients from all over India were categorized into different groups according to their serological profile. HBV DNA was detected upon amplification in 166/263 patients in group A, 3/14 patients in group B, and 2/32 patients in group C, and was not detected in groups D and E. The presence of HBV DNA in 49 patients with non-replicative HBV disease, as defined by the absence of HBeAg, suggests low levels of viremia which is also supported by the abnormal liver function tests (LFTs) in these patients. In addition, HBV DNA was detected in small proportion of individuals with past HBV infection. This data suggests that, detection of HBV DNA by amplification technique serves as an important supplementary tool besides serology in a number of clinical settings, especially in determining low levels of viremia in patients with non-replicative HBV disease and chronic hepatitis, and also in a few patients with past HBV infection and who could be asymptomatic carriers of HBV infection.

Published
2007

6. Utility of in vitroproton magnetic resonance spectroscopy in aetiological characterisation of brain abscesses

Author

Menon, S, Bharadwaj, R, Chowdhary, AS, Kaundinya, DV, and Palande, DA

Abstract

Purpose:Brain abscesses often present an aetiological dilemma. Microscopy is insensitive and culture techniques are time consuming. Hence, a new rapid technique in vitroProton Magnetic Resonance Spectroscopy (1HMRS) was evaluated for its usefulness in the identification of aetiology of brain abscesses. Materials and Methods:A total of 39 pus specimens from brain abscesses were subjected to in vitro1HMRS. These pus specimens were also processed by conventional culture methods. The spectral patterns generated by in vitro1HMRS were further correlated with culture results. Results:Pus specimens which showed the presence of anaerobes on culture revealed the presence of multiplet at 0.9 ppm (100%), lactate-lipid at 1.3 ppm (100%), acetate at 1.92 ppm (100%) and succinate at 2.4 ppm (75%). Pus specimens that revealed the presence of facultative anaerobes on culture showed a pattern B, i.e., the presence of lactate-lipid at 1.3 ppm (100%), acetate at 1.92 ppm (88.88%) along with the multiplet at 0.9 ppm (100%). Pattern C was seen in aerobic infection which showed the presence of lactate-lipid at 1.3 ppm (100%) along with the multiplet at 0.9 ppm. Pus from two tuberculous abscesses showed the complete absence of multiplet at 0.9 ppm. Conclusions:We observed in this study that it was possible to differentiate bacterial and tuberculous brain abscesses using in vitro1HMRS. Further, it was also possible to distinguish between aerobic and anaerobic brain abscesses on the basis of spectral patterns. In vitro1HMRS of fungal and actinomycotic brain abscess are also presented for its unusual spectra.

Published
2010
Full Text
View/download PDF

7. Cytomegalovirus reactivation in a SARS-CoV-2 infected woman experiencing fetal demise in the first trimester with fetal trisomy 21: A case report.

Author

Pande S, Gandhewar M, Gaikwad P, Shende P, Munne K, Bhor VM, Das D, Bashani D, Bhase M, Rathore A, Shah K, Gawde H, Padwal V, Bhagat S, Menon S, Palav H, Sachdeva G, and Patel V

Subjects
Pregnancy, Female, Humans, SARS-CoV-2, Cytomegalovirus, Pregnancy Trimester, First, RNA, Viral, Fetus, Fetal Death, Down Syndrome, COVID-19, Cytomegalovirus Infections
Abstract

Cytomegalovirus (CMV) is the most common cause of congenital viral infections. Women seropositive for CMV prior to pregnancy can develop a non-primary CMV infection. Here, we present a case of first trimester pregnancy loss during active SARS-CoV-2 infection. There was no evidence of SARS-CoV-2 RNA in placenta and fetal tissue, but there was presence of congenital cytomegalovirus infection by nested PCR. To the best of our knowledge, this is the first report demonstrating association of early congenital CMV infection due to reactivation and fetal demise in a SARS-CoV-2 positive woman with fetal trisomy 21., Competing Interests: Conflict of interest statement All authors hereby declares that there is no any financial and personal relationships with other people or organizations that could inappropriately influence their work. There is no conflict of interest., (Copyright © 2022 Indian Association of Medical Microbiologists. Published by Elsevier B.V. All rights reserved.)

Published
2023
Full Text
View/download PDF

8. Significance of HBV DNA by PCR over serological markers of HBV in acute and chronic patients.

Author

Rodrigues C, Deshmukh M, Jacob T, Nukala R, Menon S, and Mehta A

Abstract

A study was undertaken to determine Hepatitis B virus DNA (HBV DNA) by PCR in acute and chronic hepatitis B infection and to correlate it with serological markers. Three hundred and forty-five serum samples of patients from all over India were categorized into different groups according to their serological profile. HBV DNA was detected upon amplification in 166/263 patients in group A, 3/14 patients in group B, and 2/32 patients in group C, and was not detected in groups D and E. The presence of HBV DNA in 49 patients with non-replicative HBV disease, as defined by the absence of HBeAg, suggests low levels of viremia which is also supported by the abnormal liver function tests (LFTs) in these patients. In addition, HBV DNA was detected in small proportion of individuals with past HBV infection. This data suggests that, detection of HBV DNA by amplification technique serves as an important supplementary tool besides serology in a number of clinical settings, especially in determining low levels of viremia in patients with non-replicative HBV disease and chronic hepatitis, and also in a few patients with past HBV infection and who could be asymptomatic carriers of HBV infection.

Published
2001

Catalog

Books, media, physical & digital resources
See catalog results